Maria Palasis to Sell 2,812 Shares of Beta Bionics Inc.

Maria Palasis, a director of Beta Bionics Inc., has filed a notice to sell 2,812 shares of common stock acquired through the vesting of restricted stock units. The shares were acquired on September 1, 2025, and the sale is planned for October 31, 2025. The aggregate market value of the shares to be sold is approximately $75,305.36. The sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. There are no recent transactions reported in the past three months.